GB202108773D0 - Binding domain - Google Patents
Binding domainInfo
- Publication number
- GB202108773D0 GB202108773D0 GBGB2108773.9A GB202108773A GB202108773D0 GB 202108773 D0 GB202108773 D0 GB 202108773D0 GB 202108773 A GB202108773 A GB 202108773A GB 202108773 D0 GB202108773 D0 GB 202108773D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- binding domain
- domain
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2108773.9A GB202108773D0 (en) | 2021-06-18 | 2021-06-18 | Binding domain |
| EP22740453.0A EP4355781A1 (en) | 2021-06-18 | 2022-06-17 | Anti-cd307e single-domain antibodies, uses thereof in car t-cell and for the treatment of diseases |
| US18/570,278 US20250289891A1 (en) | 2021-06-18 | 2022-06-17 | Anti-cd307e single-domain antibodies, uses thereof in car t-cell and for the treatment of diseases |
| PCT/GB2022/051550 WO2022263855A1 (en) | 2021-06-18 | 2022-06-17 | Anti-cd307e single-domain antibodies, uses thereof in car t-cell and for the treatment of diseases |
| CA3223034A CA3223034A1 (en) | 2021-06-18 | 2022-06-17 | Anti-cd307e single-domain antibodies, uses thereof in car t-cell and for the treatment of diseases |
| JP2023577365A JP2024523316A (en) | 2021-06-18 | 2022-06-17 | Anti-CD307E single domain antibodies in CAR T cells and for the treatment of diseases, their uses |
| AU2022292159A AU2022292159A1 (en) | 2021-06-18 | 2022-06-17 | Anti-cd307e single-domain antibodies, uses thereof in car t-cell and for the treatment of diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2108773.9A GB202108773D0 (en) | 2021-06-18 | 2021-06-18 | Binding domain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB202108773D0 true GB202108773D0 (en) | 2021-08-04 |
Family
ID=77050440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB2108773.9A Ceased GB202108773D0 (en) | 2021-06-18 | 2021-06-18 | Binding domain |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB202108773D0 (en) |
-
2021
- 2021-06-18 GB GBGB2108773.9A patent/GB202108773D0/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202103773TA (en) | Binding domain | |
| GB201802201D0 (en) | Binding agents | |
| GB202116490D0 (en) | Post-quantum certificate binding | |
| GB201901305D0 (en) | Specific binding molecules | |
| GB202014302D0 (en) | Domain adaptation | |
| IL287555A (en) | Binding molecules | |
| GB201915282D0 (en) | Specific binding molecules | |
| IL288561A (en) | Anti-gal9 immune-inhibiting binding molecules | |
| GB202018946D0 (en) | Karakuri Big Book | |
| GB201819434D0 (en) | Domain adaptation | |
| GB202112923D0 (en) | Binding domain | |
| IL288562A (en) | Activating anti-gal9 binding molecules | |
| GB201906118D0 (en) | Anti-LAG-3 binding molecules | |
| GB201904328D0 (en) | Specific binding molecules | |
| GB202103706D0 (en) | CD160 binding domain | |
| GB202112924D0 (en) | Binding domain | |
| GB202108799D0 (en) | Binding domain | |
| GB202108824D0 (en) | Binding domain | |
| GB202108826D0 (en) | Binding domain | |
| GB202108773D0 (en) | Binding domain | |
| GB202213988D0 (en) | Binder | |
| GB202308823D0 (en) | Binding domain | |
| GB202305030D0 (en) | Binding domain | |
| ZA202200734B (en) | Binding members | |
| GB202208871D0 (en) | Binding domain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |